![PRD_002071 PRD_002071](https://data.pdbj.org/pdbjplus/data/cc/svg/TDV.svg) | PRD_002071 | Name: | 1-[(2S,4S)-4-[4-(4-fluorophenyl)-1,2,3-triazol-1-yl]-2-pyrrolidin-1-ylcarbonyl-pyrrolidin-1-yl]-4-phenyl-butan-1-one | Formula: | C27 H30 F N5 O2 | Description: | P2-substituted N-acyl-prolylpyrrolidine inhibitor | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002076 PRD_002076](https://data.pdbj.org/pdbjplus/data/cc/svg/X92.svg) | PRD_002076 | Name: | RAMIPRILAT | Formula: | C21 H28 N2 O5 | Definition date: | 2013-05-29 | Last modified: | 2013-05-29 |
|
![PRD_002077 PRD_002077](https://data.pdbj.org/pdbjplus/data/cc/svg/X93.svg) | PRD_002077 | Name: | TRANDOLAPRILAT | Formula: | C22 H30 N2 O5 | Definition date: | 2013-05-29 | Last modified: | 2018-03-13 |
|
![PRD_001039 PRD_001039](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001039.svg) | PRD_001039 | Name: | BICYCLIC PEPTIDE INHIBITOR UK504 | Formula: | C55 H94 N23 O16 S4 | Definition date: | 2013-05-15 | Last modified: | 2013-06-03 |
|
![PRD_000924 PRD_000924](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000924.svg) | PRD_000924 | Name: | Ac-DEVD-CMK | Formula: | C21 H33 Cl N4 O11 | Definition date: | 2013-05-08 | Last modified: | 2013-06-03 |
|
![PRD_001031 PRD_001031](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001031.svg) | PRD_001031 | Name: | Microcystin-LR (MCLR) bound form | Formula: | C49 H77 N10 O12 | Definition date: | 2013-05-08 | Last modified: | 2023-11-03 |
|
![PRD_001053 PRD_001053](https://data.pdbj.org/pdbjplus/data/cc/svg/Y3A.svg) | PRD_001053 | Name: | N-[(benzyloxy)carbonyl]glycyl-N-[(2S,3R)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]glycinamide | Formula: | C22 H26 Cl N3 O5 | Description: | The chlorormethyl ketone inhibitor linked to the protein through two covalent bonds with the active site serine and histidine | Definition date: | 2013-05-08 | Last modified: | 2014-09-29 |
|
![PRD_001041 PRD_001041](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001041.svg) | PRD_001041 | Name: | TMC-95A mimic ligand yCP:4e | Formula: | C61 H83 N9 O10 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001044 PRD_001044](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001044.svg) | PRD_001044 | Name: | TMC-95A mimic ligand yCP:3a | Formula: | C60 H80 N8 O11 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001045 PRD_001045](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001045.svg) | PRD_001045 | Name: | TMC-95A mimic ligand yCP:4a chain P | Formula: | C43 H47 N5 O9 | Definition date: | 2013-05-01 | Last modified: | 2013-06-03 |
|
![PRD_001049 PRD_001049](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001049.svg) | PRD_001049 | Name: | TMC-95A mimic ligand yCP:4a chain Q | Formula: | C55 H72 N8 O9 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_000915 PRD_000915](https://data.pdbj.org/pdbjplus/data/cc/svg/1KR.svg) | PRD_000915 | Name: | benzyl [(2S)-1-({(2R)-1-[(1S,2S)-2-{[(2R,3S,4S)-3-formyl-2-hydroxy-4-methylhexanoyl]amino}cyclopropyl]-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C32 H43 N3 O6 | Definition date: | 2013-04-17 | Last modified: | 2013-04-17 |
|
![PRD_000940 PRD_000940](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000940.svg) | PRD_000940 | Name: | D-PHE-PRO-D-ARG-D-THR DERIVED DIRECT THROMBIN INHIBITOR | Formula: | C24 H39 N8 O5 | Definition date: | 2013-04-17 | Last modified: | 2013-06-03 |
|
![PRD_001012 PRD_001012](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001012.svg) | PRD_001012 | Name: | Pyrrhocoricin | Formula: | C72 H120 N16 O18 | Definition date: | 2013-04-17 | Last modified: | 2013-04-17 |
|
![PRD_001014 PRD_001014](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001014.svg) | PRD_001014 | Name: | APO-monomer | Formula: | C115 H198 N39 O24 | Definition date: | 2013-04-17 | Last modified: | 2013-06-03 |
|
![PRD_000903 PRD_000903](https://data.pdbj.org/pdbjplus/data/cc/svg/0JR.svg) | PRD_000903 | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-{3-oxo-3-[(pyridin-3-ylmethyl)amino]propyl}butanamide | Formula: | C15 H23 N3 O4 | Definition date: | 2013-04-10 | Last modified: | 2013-04-10 |
|
![PRD_000907 PRD_000907](https://data.pdbj.org/pdbjplus/data/cc/svg/LDZ.svg) | PRD_000907 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide | Formula: | C26 H41 N3 O5 | Definition date: | 2013-04-10 | Last modified: | 2013-04-10 |
|
![PRD_001043 PRD_001043](https://data.pdbj.org/pdbjplus/data/cc/svg/PN4.svg) | PRD_001043 | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide | Formula: | C14 H28 N2 O4 | Definition date: | 2013-04-10 | Last modified: | 2013-04-10 |
|
![PRD_000922 PRD_000922](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000922.svg) | PRD_000922 | Name: | PL-42 | Formula: | C39 H63 N9 O14 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
![PRD_000780 PRD_000780](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000780.svg) | PRD_000780 | Name: | PL-49 | Formula: | C36 H63 N9 O11 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
![PRD_000960 PRD_000960](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000960.svg) | PRD_000960 | Name: | N-[(benzyloxy)carbonyl]-L-valyl-L-alpha-glutamyl-N-[(2R)-1-carboxy-3-oxo-4-(2,3,5,6-tetrafluorophenoxy)butan-2-yl]-L-isoleucinamide | Formula: | C35 H42 F4 N4 O11 | Definition date: | 2013-03-20 | Last modified: | 2013-06-03 |
|
![PRD_000889 PRD_000889](https://data.pdbj.org/pdbjplus/data/cc/svg/15U.svg) | PRD_000889 | Name: | (2R,4R)-4-methyl-1-(N~2~-{[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}-L-arginyl)piperidine-2-carboxylic
acid | Formula: | C23 H36 N6 O5 S | Definition date: | 2013-03-13 | Last modified: | 2013-03-13 |
|
![PRD_000967 PRD_000967](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000967.svg) | PRD_000967 | Name: | macrocyclic peptidomimetic | Formula: | C56 H84 N16 O9 | Definition date: | 2013-03-06 | Last modified: | 2013-06-07 |
|
![PRD_000882 PRD_000882](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000882.svg) | PRD_000882 | Name: | MonodeChloro- Teicoplanin A2-2 | Formula: | C88 H98 Cl N9 O33 | Definition date: | 2013-03-06 | Last modified: | 2013-06-03 |
|
![PRD_000941 PRD_000941](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000941.svg) | PRD_000941 | Name: | [Aba5,14]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|